Effectiveness of Intratympanic Dexamethasone With Ligmocaine for Alleviation of Tinnitus
Status:
Active, not recruiting
Trial end date:
2021-05-01
Target enrollment:
Participant gender:
Summary
Objective: To determine the effectiveness of Intratympanic dexamethasone with lignocaine in
control of idiopathic tinnitus.
Methodology: 264 consenting patients with idiopathic unilateral tinnitus presenting at ENT
Department were assessed for tinnitus severity using Modified Tinnitus Handicap Inventory and
the scores recorded and subsequently administered intratympanically 2.0 ml (milliliter's) of
dexamethasone and lignocaine (1.5 ml dexamethasone + 0.5 ml 1% lignocaine). The dose was
repeated twice at weekly intervals. All patients were re assessed on Modified Tinnitus
Handicap Inventory two weeks after third Intratympanic administration.